Comprehensive Stroke Care and Outcomes: Time for a Paradigm Shift.


Journal

Stroke
ISSN: 1524-4628
Titre abrégé: Stroke
Pays: United States
ID NLM: 0235266

Informations de publication

Date de publication:
01 2021
Historique:
pubmed: 23 12 2020
medline: 20 4 2021
entrez: 22 12 2020
Statut: ppublish

Résumé

Worldwide, stroke is prevalent, costly, and disabling in >80 million survivors. The burden of stroke is increasing despite incredible progress and advancements in evidence-based acute care therapies and despite the substantial changes being made in acute care stroke systems, processes, and quality metrics. Although there has been increased global emphasis on the importance of postacute stroke care, stroke system changes have not expanded to include postacute care and outcome follow-up. Our objectives are to describe the gaps and challenges in postacute stroke care and suboptimal stroke outcomes; to report on stroke survivors' and caregivers' perceptions of current postacute stroke care and their call for improvements in follow-up services for recovery and secondary prevention; and, ultimately, to make the case that a paradigm shift is needed in the definition of comprehensive stroke care and the designation of Comprehensive Stroke Center. Three recommendations are made for a paradigm shift in comprehensive stroke care: (1) criteria should be established for designation of rehabilitation readiness for Comprehensive Stroke Centers, (2) The American Heart Association/American Stroke Association implement an expanded Get With The Guidelines-Stroke program and criteria for comprehensive stroke centers to be inclusive of rehabilitation readiness and measure outcomes at 90 days, and (3) a public health campaign should be launched to offer hopeful and actionable messaging for secondary prevention and recovery of function and health. Now is the time to honor the patients' and caregivers' strongest ask: better access and improved secondary prevention, stroke rehabilitation, and personalized care.

Identifiants

pubmed: 33349012
doi: 10.1161/STROKEAHA.120.029678
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

385-393

Auteurs

Pamela W Duncan (PW)

Department of Neurology, Wake Forest School of Medicine, Winston-Salem, NC (P.W.D., C.B., M.S., S.C., M.R.).

Cheryl Bushnell (C)

Department of Neurology, Wake Forest School of Medicine, Winston-Salem, NC (P.W.D., C.B., M.S., S.C., M.R.).

Mysha Sissine (M)

Department of Neurology, Wake Forest School of Medicine, Winston-Salem, NC (P.W.D., C.B., M.S., S.C., M.R.).

Sylvia Coleman (S)

Department of Neurology, Wake Forest School of Medicine, Winston-Salem, NC (P.W.D., C.B., M.S., S.C., M.R.).

Barbara J Lutz (BJ)

School of Nursing, University of North Carolina at Wilmington (B.J.L.).

Anna M Johnson (AM)

Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina at Chapel Hill (A.M.J.).

Meghan Radman (M)

Department of Neurology, Wake Forest School of Medicine, Winston-Salem, NC (P.W.D., C.B., M.S., S.C., M.R.).

Janet Pvru Bettger (J)

School of Nursing, Duke University, Durham, NC (J.P.B.).

Richard D Zorowitz (RD)

Department of Rehabilitation Medicine, MedStar National Rehabilitation Network and Georgetown University School of Medicine, Washington, DC (R.D.Z.).

Joel Stein (J)

Department of Rehabilitation Medicine, Cornell University, Weill Cornell Medical College, New York, NY (J.S.).

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH